A Three lncRNA Set: AC009975.1, POTEH-AS1 and AL390243.1 as Nodal Efficacy Biomarker of Neoadjuvant Therapy for HER-2 Positive Breast Cancer

PURPOSE: The study aimed to explore whether the expression of lncRNAs in primary tumors could predict nodal efficacy after neoadjuvant therapy (NAT) for HER2+ breast cancer. METHODS: Total RNA was extracted from HER2+ breast cancer tissues before NAT (n=103) and from 48 pairs of cancers and para-can...

Descripción completa

Detalles Bibliográficos
Autores principales: Bi, Zhao, Qiu, Peng-Fei, Zhang, Yue, Song, Xing-Guo, Chen, Peng, Xie, Li, Wang, Yong-Sheng, Song, Xian-Rang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8685269/
https://www.ncbi.nlm.nih.gov/pubmed/34938660
http://dx.doi.org/10.3389/fonc.2021.779140

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8685269/
https://www.ncbi.nlm.nih.gov/pubmed/34938660
http://dx.doi.org/10.3389/fonc.2021.779140

Ejemplares similares